Pier Selenica

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

Zhiqiang Li, Pedram Razavi, Qing Li et al. · Cancer Cell · 2018 · 521 citations · Full text

Medicine, Cancer Biology, Cell Biology +16

Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer

Kevin Boehm, Emily A. Aherne, Lora H. Ellenson et al. · Nature Cancer · 2022 · 340 citations · Full text

Medicine, Oncology, Pathology +17

Diverse <i>BRCA1</i> and <i>BRCA2</i> Reversion Mutations in Circulating Cell-Free DNA of Therapy-Resistant Breast or Ovarian Cancer

Britta Weigelt, Iñaki Comino‐Méndez, Ino de Bruijn et al. · Clinical Cancer Research · 2017 · 258 citations

Medicine, Molecular Genetics, Oncology +16

Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Alejandro Jiménez-Sánchez, Paulina Cybulska, Katherine LaVigne Mager et al. · Nature Genetics · 2020 · 253 citations · Full text

Medicine, Immunology, Oncology +12

ARID1A determines luminal identity and therapeutic response in estrogen-receptor-positive breast cancer

Guotai Xu, Sagar Chhangawala, Emiliano Cocco et al. · Nature Genetics · 2020 · 240 citations · Full text

Medicine, Genetics, Oncology +16